ArticleLeukemia2026

A novel CD7-directed antibody-drug conjugate targeting BCL-XL with potent anti-leukemic activity in T-cell acute lymphoblastic leukemia.

Mariana L Oliveira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.